XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK COMPENSATION
3 Months Ended
Mar. 31, 2022
STOCK COMPENSATION  
Note - 4 Stock Compensation

4. STOCK COMPENSATION

 

The fair value of restricted stock awards is estimated to be the market price of the Company’s common stock at the close of the date of grant. Restricted stock activity during the three months ended March 31, 2022, is as follows:

 

 

 

Performance-

Based

 

 

Service-

Based

 

 

Number

of

Shares

 

 

Weighted

 Average

 Grant

Date Fair

Value

 per

 Share

 

Non-vested, December 31, 2021

 

 

42,466

 

 

 

40,054

 

 

 

82,520

 

 

$12.45

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Vested

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-vested, March 31, 2022

 

 

46,466

 

 

 

40,054

 

 

 

82,520

 

 

$12.45

 

 

The actual number of performance-based shares of common stock of the Company, if any, to be earned by the award recipients is determined over a three year performance measurement period based on measures that include Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) margin, revenue growth, and free cash flow. The EBITDA margin and revenue growth performance targets have been set for each of the Minimum, Target, and Maximum levels. The actual performance amount received is determined by the Compensation Committee and may be adjusted for items determined to be unusual in nature or infrequent in occurrence. A smaller portion is also earned based on Board discretion and continued service. The stock compensation cost is recognized over the requisite performance/service period using the straight-line method and can be periodically adjusted for the probable number of shares to be awarded.

 

Stock compensation (in thousands) for the three month period ended March 31, 2022 was approximately $126, based upon the value at the date of grant. Stock compensation for the three month period ended March 31, 2021 was approximately $41, based upon the value at the date of grant. There was $822 of unrecognized compensation cost related to the non-vested restricted stock as of March 31, 2022.